Literature DB >> 24768214

"Add-on" is scientifically more accurate than "placebo control" in multiple inflammatory bowel disease (IBD) trials.

Robert John Greenstein1, D W Cameron2, Sheldon T Brown1.   

Abstract

Entities:  

Keywords:  Anti-inflammatory; Clinical trials; Crohn's disease; Immunemodulators; Placebo; Ulcerative colitis

Mesh：

Substances：

Year:  2014        PMID： 24768214     DOI： 10.1016/j.crohns.2014.03.015

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  3 in total

1.  Comparison of a mycobacterial phage assay to detect viable Mycobacterium avium subspecies paratuberculosis with standard diagnostic modalities in cattle with naturally infected Johne disease.

Authors:  Robert J Greenstein; Liya Su; Irene R Grant; Antonio C G Foddai; Amy Turner; Jason S Nagati; Sheldon T Brown; Judith R Stabel
Journal:  Gut Pathog       Date:  2021-05-06       Impact factor: 4.181

2.  Yet Another Flawed "Placebo Controlled" Study in Crohn's Disease?

Authors:  Robert J Greenstein; D William Cameron; Sheldon T Brown
Journal:  Foodborne Pathog Dis       Date:  2015-06-25       Impact factor: 3.171

3.  RHB-104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn's disease associated with Mycobacterium paratuberculosis.

Authors:  Karel P Alcedo; Saisathya Thanigachalam; Saleh A Naser
Journal:  Gut Pathog       Date:  2016-06-14       Impact factor: 4.181
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.